Neurocrine Biosciences Reports Positive Data Of Valbenazine For Chorea In Huntington Disease

Neurocrine Biosciences, Inc. (NBIX) announced results from the phase 3 KINECT-HD study, which showed once-daily administration of valbenazine was associated with significant improvement in chorea associated with Huntington disease compared with placebo. Valbenazine met the primary endpoint of significant improvement in Chorea severity versus placebo, with improvements beginning in week 2. The company noted that the secondary endpoints of clinical global impression of change response status and patient global impression of change response status also significantly favored valbenazine treatment.

The safety and tolerability of valbenazine in chorea associated with Huntington disease continues to be evaluated in KINECT-HD2, the company noted.

Eiry Roberts, Chief Medical Officer at Neurocrine Biosciences, said: "Data from the KINECT-HD and the ongoing KINECT-HD2 study will form the basis of our supplemental new drug application for submission to the U.S. Food and Drug Administration later this year."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT